Enanta Pharmaceuticals
ENTA
#7652
Rank
โ‚น37.68 B
Marketcap
โ‚น1,296
Share price
-2.21%
Change (1 day)
192.78%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -โ‚น6.55 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น65.32 Million. In 2024 the company made an earning of -โ‚น9.31 Billion, an increase over its 2023 earnings that were of -โ‚น12.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น6.55 Billion-29.63%
2024 -โ‚น9.31 Billion-23.87%
2023 -โ‚น12.23 Billion4.39%
2022 -โ‚น11.72 Billion-4.4%
2021 -โ‚น12.26 Billion91.12%
2020 -โ‚น6.42 Billion-407.13%
2019 โ‚น2.08 B-78.63%
2018 โ‚น9.76 B117.97%
2017 โ‚น4.48 B-574.65%
2016 -โ‚น0.95 Billion-110.83%
2015 โ‚น8.72 B-4.5%
2014 โ‚น9.13 B-638.53%
2013 -โ‚น1.7 Billion-137.98%
2012 โ‚น4.46 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.492 T-34,342.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.514 T-20,904.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚น633.01 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น485.71 B-6,771.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.262 T-17,435.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น920.88 B-12,749.60%๐Ÿ‡บ๐Ÿ‡ธ USA